BLCO vs TECH · rev $4.79B vs P/E 65, rev $1.22B
Bausch + Lomb Corp (BLCO) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Bausch + Lomb Corp (BLCO) is a medical instruments & supplies company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported BLCO revenue for 2024-12-31 was $4.79B. Net income was -$305.0M. Revenue was up 15.6% from 2023-12-31 to 2024-12-31. BLCO currently screens at market cap $5.38B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
BLCO currently screens at market cap $5.38B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the BLCO and TECH stock pages for the full models.
Not investment advice.